Taiwania Capital Management Corporation

Opsera empowers software and DevOps engineers by offering a cloud-based continuous orchestration platform. This platform enables the use of preferred CI/CD tools, reduces manual scripting, and provides unified insights across the entire DevOps lifecycle. It aims to increase software velocity, improve operational efficiency, and offer unparalleled visibility for business leaders.

Health2Sync is a healthcare technology company that converts legacy medical devices into smart, connected tools by leveraging smartphone capabilities. Its flagship product is an app paired with an accessory for intelligent blood glucose monitoring, enabling users to track readings, share data with loved ones and clinicians, and receive personalized insights for better diabetes management.

Syncell is a proteomics technology company focused on advancing disease-specific protein drug target discovery. Utilizing its innovative Microscoop™ technology, Syncell enables microscopy-guided nanoscale protein "scooping," which allows for unbiased subcellular spatial proteomic discovery. This groundbreaking approach transforms high-content microscopy into a precise photolabeling system, addressing complex biological challenges and facilitating high-content de novo spatial proteomics. By enabling researchers to identify novel proteins and biomarkers within specific subcellular locations, Syncell aims to enhance the understanding of diseases and support the discovery of new therapeutic targets.

Founded in 2018, Path Robotics specializes in manufacturing autonomous welding robots that incorporate AI and machine learning. These robots automate repetitive tasks, enhancing precision and adaptability while increasing productivity for manufacturers.

All Eyes On Screens develops an advanced advertisement platform that collects, integrates, extracts, and visualizes data. Its mission is to enhance TV advertising effectiveness, transparency, speed, and comparability with digital channels.

DataPelago develops big data analytics solutions and a comprehensive analytics platform that enables the extraction of insights from data of any scale, speed, or structure. The platform delivers instantaneous insights with strong performance and cost efficiency, helping organizations solve complex challenges across all layers of the data stack.

TXOne Networks specializes in industrial cybersecurity, safeguarding operational technology (OT) networks and critical infrastructure against cyber threats. The company offers network-based and endpoint-based security solutions that provide real-time, comprehensive protection for industrial control systems (ICS) across various sectors such as smart manufacturing, smart cities, and smart energy. TXOne's products enable both IT and OT teams to have clear visibility into ICS assets, protocols, risks, and threats, ensuring reliable and safe operations.

ARRIS specializes in developing additive molding technology for manufacturing large-scale 3D-aligned continuous fiber thermoplastic composite parts. Its innovative process combines aligned fibers, electronics, and metallic components within topology-optimized structures, serving industries such as aerospace, automotive, and consumer products.

TransferGo is a global money transfer company that enables individuals and businesses to send money internationally through a digital account-to-account platform. Headquartered in London, it offers online transfers with same-day delivery to selected destinations and aims to provide economical rates compared with banks and cash bureaus. The service targets migrant workers sending funds home and businesses paying suppliers, charging a fixed transfer fee and a currency conversion margin per transaction.

Daytrip Europe Ltd is a travel platform that connects tourists with local drivers for inter-city transportation. Founded in 2015 and based in London, the platform allows travelers to book private door-to-door transfers by entering their origin and destination. This service not only facilitates convenient travel between cities but also offers an opportunity to explore local sights and culture during the journey. Travelers can experience the region's countryside and engage with local drivers, enhancing their vacation with authentic insights into the area's history and customs. Daytrip aims to combine the comfort of traditional travel with the flexibility of independent exploration, making it a unique option for those seeking a more immersive travel experience.

SKY ENGINE AI is a synthetic data cloud generative AI platform for data scientists enabling ai computer vision at scale software allows creating a digital twin of your sensor, drone, or robot and putting them through testing and training in a virtual environment prior to real-world deployment. They are data generation makes data scientist life easier providing perfectly balanced datasets for any computer vision applications like object detection and recognition. They include 3d positioning, pose estimation, and other sophisticated cases including analysis of multi-sensor data radars, lidars, satellites, x-rays, and more.

VRgineers specializes in developing high-fidelity virtual reality (VR) headsets and simulators for professional training, particularly in aerospace. Their flagship product, XTAL, offers industry-leading resolution and field of view, enhancing pilot experience and situational awareness. They serve prominent clients such as the U.S. Air Force, NASA, and major automotive brands.

Surglasses is a Taiwanese medical technology company specializing in the development and distribution of innovative surgical navigation and educational solutions. The company's patented technology is used in high-performance surgical systems and educational products, offering a cost-effective alternative to traditional surgical planning tools. Surglasses' products, including the CE-approved Foresee-X smart surgical glasses with Augmented Reality, and the Caduceus for spine surgical navigation with 3D Mixed Reality, aim to enhance surgery safety, precision, and efficiency. The company, certified with CE Mark, ISO-13485, and GMP, is committed to continuous R&D to meet the needs of surgeons, physicians, and patients, and to contribute to advancements in medical electronics and minimally invasive surgery.

Opsera empowers software and DevOps engineers by offering a cloud-based continuous orchestration platform. This platform enables the use of preferred CI/CD tools, reduces manual scripting, and provides unified insights across the entire DevOps lifecycle. It aims to increase software velocity, improve operational efficiency, and offer unparalleled visibility for business leaders.

Flat Medical specializes in developing safety technology solutions for clinical processes. Their innovative technology is employed during surgical procedures to detect and prevent potential errors, thereby enhancing the precision and safety of treatments administered by clinical professionals.

QT Medical is a developer of innovative medical devices focused on enhancing heart health through technology. The company offers a wireless electrocardiogram (ECG) that allows patients to measure their heart conditions with greater accuracy and convenience. By enabling users to perform diagnostic, hospital-grade ECG scans from home or any location with internet access, QT Medical empowers patients to take an active role in managing their heart disease. This approach not only alleviates the need for frequent visits to cardiologists or hospitals but also provides patients with peace of mind, saves time, reduces stress, and ultimately improves health outcomes. The devices feature an on-screen virtual caliper that enables physicians to quickly assess interval and duration data, facilitating better monitoring of cardiac health.

Sensoneo is a global provider of enterprise‑grade smart waste management solutions that help cities and businesses reduce costs and environmental impact. The company combines in‑house ultrasonic sensors—Single, Double, Quatro, and patent‑pending Micro‑sensors—with advanced software that delivers real‑time monitoring, analytics, route planning, and vehicle load optimization. By enabling data‑driven decisions, Sensoneo’s platform can cut waste‑collection costs by at least 30 % and lower carbon emissions by up to 60 %. Its solutions are deployed in numerous locations across Europe, North America, South America, the Middle East, Australia, and New Zealand, and include incentive programs that encourage waste reduction and streamline the entire waste lifecycle.

Ethernovia specializes in developing advanced Ethernet systems for vehicles. By integrating high-performance components and utilizing artificial intelligence-driven interconnects, the company enhances autonomous driving capabilities, optimizes in-vehicle data flow, and ensures reliable communication networks.

AnHorn Medicines is a drug discovery company focused on developing therapeutics for cancer, neurodegenerative disorders, and aging-related diseases. It builds a pipeline of protein degradation drugs using an AI-enabled platform to identify candidates that target and degrade disease-related proteins. The company aims to provide a novel class of treatments that address life-threatening and life-impairing conditions that are difficult to treat and prone to resistance, enabling researchers and clinicians to pursue new therapeutic options.

3drens offers a B2B software solution, the Fleet Intelligence Platform. This IoT-based platform serves commercial fleet owners in logistics, vehicle rentals, transportation, and automakers, aiming to enhance operational efficiency, safety, and sustainability through data-driven insights.

Genialis, Inc. is a computational precision medicine company that specializes in the development of a web-based software platform for biological data management, analysis, visualization, and interpretation. Founded in 2011 and based in Houston, Texas, the company focuses on unraveling complex biology to discover actionable biomarkers that can enhance disease treatment. Its platform combines a range of visual analytics and bioinformatics tools, facilitating the storage and tracking of data while automating primary analyses to ensure reproducibility. Genialis enables non-experts to access sophisticated downstream analyses and supports secure sharing of data insights. The company's efforts aim to assist pharmaceutical and diagnostics companies in developing more effective drugs and deploying tests that improve treatment decisions, thereby increasing the probability of clinical success and validating therapeutic targets.

Light Field Lab, Inc. is a technology company specializing in the development of holographic display systems that create immersive visuals by projecting three-dimensional holograms into physical space. Founded in 2017 and based in San Jose, California, the company leverages advanced light field technology to generate multiple viewing angles that mimic real-world perceptions, allowing objects to appear to float in space without the need for head-mounted displays. Light Field Lab's innovations enable new opportunities in both consumer and enterprise markets, facilitating the integration of existing content into their holographic formats through a universal application programming interface. The company's mission is to pioneer a holographic future, advancing how visual media is experienced across various applications.

Oxipit is a developer of artificial intelligence tools designed to enhance medical imaging, specifically in the area of chest radiology. The company focuses on automating the diagnosis and reporting of chest X-ray images to improve diagnostic accuracy and efficiency. Its platform utilizes advanced AI algorithms to identify images without abnormalities and generates preliminary reports only when the system is highly confident in its findings. This innovation addresses the global shortage of radiologists and allows medical specialists to concentrate their efforts on cases that require further attention, ultimately aiming for better patient outcomes worldwide.

Brightpick, headquartered near Cincinnati, Ohio, specializes in AI-driven robotics for warehouse automation. Their flagship product, the Brightpick Autopicker, is a mobile robot that autonomously handles order picking, consolidation, dispatch, and stock replenishment. This allows warehouses of any size to significantly reduce labor requirements and streamline operations, with deployment taking just weeks. The company has over 200 employees and has deployed hundreds of AI robots across the US and Europe.

Artilux is a technology company specializing in advanced optical connectivity solutions and 3D time of flight (ToF) technology. The company develops high-performance integrated circuits (ICs) that cater to a range of applications, from short-range consumer uses at 10-40G to long-range 100G data center links. Artilux is committed to innovation, having discovered GeSi, a novel 3D photosensitive material, which positions the company to enhance next-generation mobile devices. By embedding advanced optical and RF technologies into its products, Artilux aims to facilitate seamless and instantaneous data transfer, whether for consumer electronics or cloud-based applications.

Litilit is a developer of ultrafast laser technology that aims to revolutionize the industrial laser market. The company’s proprietary laser pulse generator delivers telecom-grade performance, ensuring high reliability and scalability at competitive prices. Litilit's innovations in femtosecond and self-starting laser technologies have demonstrated exceptional versatility and dependability across various industries, including medical equipment, bioimaging, consumer electronics, advanced manufacturing, 3D printing, laser surgery, and fundamental science. With a strong focus on engineering solutions tailored to meet the evolving needs of its clients, Litilit is well-positioned to become a leader in the next generation of ultra-short pulse lasers.

3nets, Inc. is a Santa Clara, CA-based company specializing in MultiCloud Networking (MCN). It offers an applications-aware elastic network infrastructure platform that addresses the application delivery needs of enterprises through its Network Fabric. The company's software-defined, cloud-native WAN platform utilizes customer-owned hardware and public cloud resources to provide scalable, end-to-end connectivity across various locations, including cloud-centric data centers, colocations, private data centers, and branch offices. By enabling businesses to manage application-based workloads efficiently, 3nets facilitates digital transformation initiatives, accelerates innovation, and simplifies operational complexities. The platform allows customers to express their requirements through a controller, which directs the software functions to deliver the necessary services effectively.

DataPelago develops big data analytics solutions and a comprehensive analytics platform that enables the extraction of insights from data of any scale, speed, or structure. The platform delivers instantaneous insights with strong performance and cost efficiency, helping organizations solve complex challenges across all layers of the data stack.

Nanolive SA is a Swiss company that specializes in the design and development of advanced imaging devices for live cells. Established in 2013 and headquartered in Ecublens, Switzerland, the company offers the 3D Cell Explorer, a cutting-edge technology that allows researchers to visualize the interior of living cells in three dimensions without the need for labeling or invasive techniques. This innovative device enables detailed observation of various cellular processes such as cell division, organelle structure, cell morphology, differentiation, and interactions between cells. By capturing unbiased live cell data, Nanolive's technology supports the research and development of new drugs and therapies, facilitating quality analysis and providing valuable biological insights for scientists and researchers in the field of life sciences.

Cognito Health is a developer of innovative healthcare technology that aims to enhance the healthcare environment by delivering increased value to both patients and healthcare systems. The company utilizes predictive algorithms to continuously monitor patients, allowing for a contact-free, data-driven approach to patient care. This technology enables healthcare professionals to anticipate potential adverse events and improve patient safety by alerting caregivers when it is necessary to reposition a patient. Additionally, Cognito Health's system can detect pressure between patients and sensors, visually mapping pressure points for clinicians. Through these advancements, Cognito Health strives to optimize patient management and improve overall healthcare outcomes.

Health2Sync is a healthcare technology company that converts legacy medical devices into smart, connected tools by leveraging smartphone capabilities. Its flagship product is an app paired with an accessory for intelligent blood glucose monitoring, enabling users to track readings, share data with loved ones and clinicians, and receive personalized insights for better diabetes management.

Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

PharmaEssentia is a biopharmaceutical company specializing in the research, development, production, and sale of therapeutic products for treating human diseases. Its primary focus areas include hematology, oncology, and infectious diseases. The company's flagship product is ropeginterferon alfa-2b, used to treat conditions such as polycythemia vera and hepatitis B/C.

EirGenix is a Taiwan-based contract development and manufacturing organization that specializes in biologics. It offers cell line development and cell bank manufacturing, process development, analytical sciences and quality control, and cGMP manufacturing, including antibody-drug conjugate production. The company operates two business units: contract development and manufacturing operation and product development operation, applying its team’s experience to biosimilars, biobetters, and new biologics. It runs two PIC/S GMP facilities for mammalian and microbial production to support clinical trial and commercial manufacturing. Founded in 2012 and headquartered in New Taipei City, EirGenix also develops and provides biopharmaceutical products such as CRM197 carrier protein and a COVID-19 antigen rapid test.

AmMax is a clinical-stage biotechnology company focused on developing innovative therapies for diseases with significant unmet medical needs. The company leverages its CSF1R platform to create anti-inflammatory, anti-fibrotic, and anti-neovascular treatments, aiming to address a variety of critical health conditions. By pursuing licensing and partnerships, AmMax seeks to build a robust oncology portfolio that targets sizable market opportunities. Its commitment to translational and clinical development positions it to unlock the therapeutic potential of its technology, ultimately enabling healthcare professionals to offer effective treatments to patients in need.

Frequency Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to repairing or reversing damage caused by degenerative diseases through its innovative Progenitor Cell Activation approach. This method utilizes a combination of small molecules to activate progenitor cells in the body, which facilitates the creation of functional tissue without the complexities of genetic engineering. The company’s lead product candidate, FX-322, is currently undergoing phase 2a clinical trials aimed at treating the underlying causes of sensorineural hearing loss. In addition to FX-322, Frequency Therapeutics is exploring treatments for various degenerative conditions, including multiple sclerosis and diseases affecting muscle, the gastrointestinal tract, skin, and bone. Established in 2014 and based in Woburn, Massachusetts, Frequency Therapeutics has established a collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322.

C4 Therapeutics is a biopharmaceutical company developing targeted protein degradation therapies using its proprietary Degronimid platform. This platform enables the selective destruction of disease-causing proteins, expanding the scope of treatable conditions and potentially reducing drug resistance. The company focuses on oncology indications and has strategic collaborations with industry leaders.

AIxMed offers a digital cytology platform that digitizes 3D cytology samples in minutes and uses AI to extract clinical insights in seconds. The platform provides bladder cancer monitoring and assisted diagnosis, helping healthcare professionals streamline workflows, reduce diagnostic and monitoring complexity, and lower cancer-related costs, with the goal of improving patient care and outcomes. The company was founded in 2018 and is headquartered in Santa Clara, California.

SyneuRx International Taiwan is a biomedical company focused on the development of innovative treatments for central nervous system disorders, particularly targeting schizophrenia, depression, and dementia. The company is advancing its clinical pipeline with several drug candidates, including SND-11, SND-12, and SND-13, the latter of which is currently undergoing Phase IIb/III clinical trials as an add-on therapy for schizophrenia. By concentrating on these critical mental health issues, SyneuRx aims to provide effective therapeutic options for patients suffering from these debilitating conditions.

TFBS Bioscience Inc is a Contract Research Organization (CRO) based in Taiwan that specializes in biological testing and offers comprehensive services for the biopharmaceutical industry. The company provides critical support for cell and gene therapy products, which includes viral vector manufacturing, biosafety testing, and product release testing. Additionally, TFBS Bioscience conducts cell bank characterization, viral clearance, bulk and lot release testing, assay development—both in vitro and in vivo— and clinical sample analysis. The organization is also involved in cleaning validation for reusable medical devices, ensuring compliance with safety standards. Through its diverse range of services, TFBS Bioscience plays a pivotal role in advancing the development and commercialization of innovative medical therapies.

FaceHeart develops AI technology that extracts six vital signs from facial videos in just 45 seconds. Its contactless solution can be integrated into devices with cameras via an SDK, offering wide-ranging applications in telehealth, elderly care, wellness, and childcare sectors.

Bigfoot Biomedical, Inc. is a medical device company focused on transforming diabetes care for individuals with Type 1 Diabetes. Established in 2014 and based in Milpitas, California, the company specializes in developing an integrated diabetes management system that features cloud connectivity and human-centered automation. This system optimizes insulin dosing and delivery through a combination of automated infusion pumps and connected insulin pen options. Bigfoot Biomedical's innovative approach employs machine learning and user-friendly technologies to alleviate the cognitive, emotional, and financial burdens associated with insulin-requiring diabetes. By offering a comprehensive digital drug delivery platform through a unique monthly subscription service model, the company aims to enhance the quality of life for patients managing their diabetes.

Regenacy Pharmaceuticals is a Boston-based biopharmaceutical company founded in 2016 that develops therapies for peripheral neuropathies, hemoglobinopathies and certain oncology indications. Its approach centers on restoring normal protein function with oral, isoform-selective histone deacetylase inhibitors. The company is advancing drug programs that include ricolinostat to address sickle cell disease and beta-thalassemia, as well as additional HDAC inhibitor–based therapies for neuropathies and related conditions.

Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors, with a particular emphasis on neurological disorders. As a late-clinical stage, venture-backed firm, Xgene utilizes proprietary linker technology to create novel, multimodal conjugated molecules. Its current programs are designed to enhance the efficacy and tolerability of pain medications, addressing unmet needs in the treatment of chronic pain and neurological conditions.

Point Robotics Medtech is an orthopedic and spine robot that optimizes clinical outcomes for patients and physicians. The company received FDA clearance for its Kinguide Robotic-Assisted Surgical System, a handheld robot that can be used in orthopedic surgeries.

Light Field Lab, Inc. is a technology company specializing in the development of holographic display systems that create immersive visuals by projecting three-dimensional holograms into physical space. Founded in 2017 and based in San Jose, California, the company leverages advanced light field technology to generate multiple viewing angles that mimic real-world perceptions, allowing objects to appear to float in space without the need for head-mounted displays. Light Field Lab's innovations enable new opportunities in both consumer and enterprise markets, facilitating the integration of existing content into their holographic formats through a universal application programming interface. The company's mission is to pioneer a holographic future, advancing how visual media is experienced across various applications.

Aesop Technology is a developer of artificial intelligence solutions focused on reducing prescription-related errors and enhancing patient safety. Founded in 2019 and based in Berkeley, California, the company offers MedGuard, an AI-enhanced safety system that supports various aspects of prescription management, including prescribing, dispensing, administering, and compliance services. Aesop Technology also provides a clinical decision support system that assists healthcare providers by flagging inappropriate prescriptions based on patient diagnosis, age, and gender. By leveraging machine learning, the company's technology aims to improve healthcare quality and safety while streamlining billing-related documentation, ultimately enhancing patient safety and the accuracy of medical billing.

Founded in 2019, Avesha is a tech platform that enables application workloads to operate across cloud, multi-cloud, and edge locations. It improves business outcomes by automating processes, enabling real-time use cases, and enhancing performance through data distribution closer to end-users. The company's SNAP platform creates a virtual overlay on any network underlay.

FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.

Founded in 2019, Verana Networks specializes in developing innovative 5G Radio Access Network solutions for service providers who have licensed millimeter wave spectrum. Its focus is on enabling high-speed and high-capacity 5G services to drive new applications and revenue growth.

Nanolive SA is a Swiss company that specializes in the design and development of advanced imaging devices for live cells. Established in 2013 and headquartered in Ecublens, Switzerland, the company offers the 3D Cell Explorer, a cutting-edge technology that allows researchers to visualize the interior of living cells in three dimensions without the need for labeling or invasive techniques. This innovative device enables detailed observation of various cellular processes such as cell division, organelle structure, cell morphology, differentiation, and interactions between cells. By capturing unbiased live cell data, Nanolive's technology supports the research and development of new drugs and therapies, facilitating quality analysis and providing valuable biological insights for scientists and researchers in the field of life sciences.

Light Field Lab, Inc. is a technology company specializing in the development of holographic display systems that create immersive visuals by projecting three-dimensional holograms into physical space. Founded in 2017 and based in San Jose, California, the company leverages advanced light field technology to generate multiple viewing angles that mimic real-world perceptions, allowing objects to appear to float in space without the need for head-mounted displays. Light Field Lab's innovations enable new opportunities in both consumer and enterprise markets, facilitating the integration of existing content into their holographic formats through a universal application programming interface. The company's mission is to pioneer a holographic future, advancing how visual media is experienced across various applications.

Canner is a provider of data management solutions that enables businesses to navigate the complexities of data and its context. The company has developed a universal semantic layer powered by artificial intelligence, which integrates schema, structure, relationships, and metadata to create a cohesive semantic framework. This innovative approach transforms how organizations interact with their data. Canner's flagship products include Canner Enterprise, an enterprise-grade semantic layer designed for robust data management, and WrenAI, an open-source AI agent that enhances data processing and understanding through its semantic capabilities. By offering a unified platform for data management, Canner empowers clients to manage, audit, analyze, and share data effectively across their organizations.

URSROBOT Inc is a leading company specializing in service robotic solutions, dedicated to bringing outdoor service robots into various aspects of daily life. With NEXMOW, we built up the robotic lawnmower solution for commercial landscaping industry. This revolutionary device combines precise outdoor navigation, AI path planning and cloud services, setting smart working way in commercial landscaping industry. With NEXMOW "drop, mow & go" solution, it can help redeploy labors and create productivities.

Pavilion Data Systems Inc. is a technology company based in San Jose, California, specializing in the design and development of NVMe-over-Fabric storage platforms. The company focuses on enabling real-time performance at scale for massively-parallel applications, offering solutions that cater to sectors such as financial services, government, cloud services, media and entertainment, and research facilities. Pavilion's innovative architecture features Hyperparallel Flash Arrays, which utilize multiple controllers to surpass the limitations of traditional storage systems, providing ultra-low latency and linear scalability. By introducing a unique model called OPENCHOICE, Pavilion challenges conventional approaches to storage procurement and deployment. Founded in 2011, Pavilion Data Systems also has offices in Schiphol, the Netherlands, and Pune, India, and is recognized as a leader in a new category of storage appliances that aims to meet the ever-increasing demand for data throughput.

Founded in 2011, WindGap Medical specializes in the development and manufacturing of compact epinephrine autoinjectors for treating anaphylaxis. Headquartered in Watertown, Massachusetts.

Appaegis simplifies enterprise data access while enforcing strong zero-trust security for remote access. Its patent-pending solution protects data access and gives administrators full control over how enterprise data is used. The company was founded by security veterans with successful security track records.

Landing AI is a company that specializes in artificial intelligence transformation programs tailored for the manufacturing industry. Founded in 2017 and based in Palo Alto, California, the company develops solutions focused on visual inspection, automation, calibration, and automated issue identification. Its offerings cater to a diverse range of sectors, including manufacturing, retail, automotive, agriculture, telecommunications, and pharmaceuticals. The company aims to empower organizations to become AI-driven by providing a platform that enhances the accuracy of machine learning models through effective data generation and labeling. This platform helps identify environmental issues and alerts users to model changes, thereby facilitating efficient data management and accelerating troubleshooting processes. Founded by Dr. Andrew Ng, a prominent figure in AI, Landing AI is positioned to deliver practical AI solutions that drive value for businesses globally.

Pavilion Data Systems Inc. is a technology company based in San Jose, California, specializing in the design and development of NVMe-over-Fabric storage platforms. The company focuses on enabling real-time performance at scale for massively-parallel applications, offering solutions that cater to sectors such as financial services, government, cloud services, media and entertainment, and research facilities. Pavilion's innovative architecture features Hyperparallel Flash Arrays, which utilize multiple controllers to surpass the limitations of traditional storage systems, providing ultra-low latency and linear scalability. By introducing a unique model called OPENCHOICE, Pavilion challenges conventional approaches to storage procurement and deployment. Founded in 2011, Pavilion Data Systems also has offices in Schiphol, the Netherlands, and Pune, India, and is recognized as a leader in a new category of storage appliances that aims to meet the ever-increasing demand for data throughput.

Ethernovia specializes in developing advanced Ethernet systems for vehicles. By integrating high-performance components and utilizing artificial intelligence-driven interconnects, the company enhances autonomous driving capabilities, optimizes in-vehicle data flow, and ensures reliable communication networks.

Elixiron Immunotherapeutics is focused on developing innovative therapeutics for cancer, neurological diseases, and inflammatory disorders. The company specializes in immuno-therapeutics aimed at addressing conditions such as neurodegenerative diseases and Hepatitis B, as well as various cancer types. Its drug candidates are designed to target specific immuno-suppressive pathways, including graft-versus-host disease and macrophage activation syndrome. By doing so, Elixiron seeks to empower patients to effectively utilize their immune systems in the fight against these serious health challenges.

AEye, Inc. is a technology company focused on developing advanced vision hardware, software, and algorithms for autonomous vehicles and advanced driver assistance systems (ADAS). The company’s proprietary 4Sight Intelligent Sensing Platform integrates solid-state active LiDAR with artificial intelligence and a low-light HD camera, enabling precise and reliable perception of surroundings. AEye's products, including the 4Sight A and 4Sight M sensors, along with its iDAR platform, are designed to improve safety and performance in dynamic applications by providing faster, more accurate information. The AE100 Robotic Perception System and the modular AE200 sensor further exemplify AEye’s commitment to high-performance sensing solutions. Founded in 2013 and headquartered in Dublin, California, AEye also has a global presence with offices in Germany and Korea, serving a diverse customer base primarily in the United States, Europe, and the Asia-Pacific region.

SafeLiShare is a developer of data security software designed to facilitate the safe sharing and publishing of sensitive and private data and programmatic assets. The company's software empowers enterprises and federations to utilize their valuable digital assets securely, enabling them to generate business insights, engage in machine learning, and conduct analytics on sensitive data. By providing a secure framework for data usage, SafeLiShare helps clients unlock new revenue streams and gain insights from their sensitive data assets, thereby fostering innovative business models.

Kdan Mobile Software Ltd. is a global company that specializes in mobile software applications and online services, aimed at enhancing productivity and creativity. Founded in 2009 and headquartered in Tainan City, Taiwan, the company has expanded its presence with offices in Taipei, Huntingdon, Changsha, Beijing, and Tokyo. Kdan Mobile offers a variety of solutions, including Creativity 365, a comprehensive content creation suite featuring applications such as Animation Desk and Write-on Video, and Document 365, which provides tools for document management, including a PDF reader and online converting services. Other notable offerings include Kdan Cloud, a collaborative workspace, DottedSign for eSignature management, and Kdan PDF SDK for developers. Additionally, Kdan Mobile features My Markups for web page sharing and AniZone for video publishing and interaction. With over 200 million downloads globally, Kdan Mobile serves a diverse clientele, empowering users to create, distribute, and manage their projects effectively across various digital platforms.

FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.

Cognito Health is a developer of innovative healthcare technology that aims to enhance the healthcare environment by delivering increased value to both patients and healthcare systems. The company utilizes predictive algorithms to continuously monitor patients, allowing for a contact-free, data-driven approach to patient care. This technology enables healthcare professionals to anticipate potential adverse events and improve patient safety by alerting caregivers when it is necessary to reposition a patient. Additionally, Cognito Health's system can detect pressure between patients and sensors, visually mapping pressure points for clinicians. Through these advancements, Cognito Health strives to optimize patient management and improve overall healthcare outcomes.

ARRIS specializes in developing additive molding technology for manufacturing large-scale 3D-aligned continuous fiber thermoplastic composite parts. Its innovative process combines aligned fibers, electronics, and metallic components within topology-optimized structures, serving industries such as aerospace, automotive, and consumer products.

Oculii Corp., based in Beavercreek, Ohio, specializes in developing advanced radar sensors and AI software for various applications, including intelligent transportation, automotive, aerial, and consumer sectors. The company's key products are radar sensors that provide real-time 4D tracking information, enabling accurate 3D positioning and speed detection. These sensors are used in automotive safety systems, traffic management, airborne and medical applications, as well as automated speed enforcement systems. Oculii's innovative Virtual Aperture Imaging radar technology enhances radar resolution without increasing the physical size of the sensor, making it more affordable and scalable. The company collaborates with industry leaders to deliver high-performance, all-weather, and low-cost perception technology for autonomous systems.

Touché Solutions, formerly known as Mechavision, specializes in the manufacture of robot sensor modules and the development of plug-in robot haptic technology products. These technologies are integral to smart manufacturing applications and Internet of Things (IoT) services. The company's innovations have been utilized by Qisda for human-machine collaboration production lines. Touché Solutions is dedicated to research and development, aiming to enhance intelligent robotic development efficiently for its clients.

Ubiik Technology, founded in 2016, specializes in Advanced Metering Infrastructure (AMI) and private LTE (pLTE) solutions. The company leverages its proprietary Weightless™ and cellular IoT LPWAN technologies to offer low-power wireless devices that connect multiple devices to a single base station. Ubiik initially focused on providing Weightless™ LPWAN, a high-performance open standard communication protocol, which has been successfully implemented in various AMI projects. Following a successful deployment in 2018, the company expanded its offerings to include a Platform as a Service (PaaS) model, positioning itself as a vertical IoT solutions provider. Ubiik's connectivity solutions now encompass LTE technologies, catering to the diverse needs of the IoT market, particularly for applications requiring robust security compliant with 3GPP standards.

Suono Bio, Inc. is a biotechnology company based in Medford, Massachusetts, that focuses on designing and developing innovative therapeutic products with a unique delivery technology. Established in 2016, the company specializes in enabling ultra-rapid, localized delivery of small molecules, biologics, nucleic acids, and gene therapies directly to the gastrointestinal tract without the need for encapsulation. Suono Bio aims to transform the treatment landscape for difficult-to-treat diseases, particularly those mediated by inflammatory processes, by facilitating effective therapy delivery that enhances patient recovery from gastrointestinal conditions.

Founded in 2019, Avesha is a tech platform that enables application workloads to operate across cloud, multi-cloud, and edge locations. It improves business outcomes by automating processes, enabling real-time use cases, and enhancing performance through data distribution closer to end-users. The company's SNAP platform creates a virtual overlay on any network underlay.

AEye, Inc. is a technology company focused on developing advanced vision hardware, software, and algorithms for autonomous vehicles and advanced driver assistance systems (ADAS). The company’s proprietary 4Sight Intelligent Sensing Platform integrates solid-state active LiDAR with artificial intelligence and a low-light HD camera, enabling precise and reliable perception of surroundings. AEye's products, including the 4Sight A and 4Sight M sensors, along with its iDAR platform, are designed to improve safety and performance in dynamic applications by providing faster, more accurate information. The AE100 Robotic Perception System and the modular AE200 sensor further exemplify AEye’s commitment to high-performance sensing solutions. Founded in 2013 and headquartered in Dublin, California, AEye also has a global presence with offices in Germany and Korea, serving a diverse customer base primarily in the United States, Europe, and the Asia-Pacific region.

Tripresso is an online travel agency based in Taipei, Taiwan, founded in 2013. The company specializes in package tour products, initially providing a marketplace for suppliers and a simple search engine for customers seeking suitable travel options. Over time, Tripresso expanded its offerings to include hotels, flight tickets, and customized travel plans for outbound travel. In 2018, it introduced TripSaaS, a proprietary software-as-a-service platform designed for brick-and-mortar travel agencies. This system facilitates the management of websites, product listings, orders, and customer relationships, ultimately enhancing operational efficiency. By leveraging data and partnerships with both online and offline travel information sources, Tripresso creates efficient travel planning networks that help users discover affordable travel packages.

Mammoth Cyber specializes in computer and network security. It develops an agentless zero-trust access system that safeguards remote, data, and web access while providing full visibility and control over user interactions with applications.

Dcard is a social networking platform based in Taipei, Taiwan, that was founded in 2015. It serves as Taiwan's largest anonymous communication platform, designed specifically for students. Dcard facilitates the sharing of ideas and experiences among users, fostering a sense of community within the campus environment. By allowing individuals to connect without the constraints of background, age, or interest, Dcard creates a comfortable and trustworthy space for students to engage and interact. The platform emphasizes anonymity, enabling users to share their thoughts and experiences freely.

Viracta Therapeutics, Inc. is a clinical-stage drug development company based in Cardiff, California, that specializes in precision oncology focused on virus-associated malignancies. The company utilizes a viral activation therapy platform to develop treatments for cancers linked to the Epstein-Barr Virus (EBV) and other virus-related diseases. Its lead investigational drug, nanatinostat, is being evaluated in combination with the antiviral valganciclovir as a potential oral therapy for EBV-positive lymphoma, including post-transplant lymphoproliferative disorder, plasmablastic lymphoma, and angioimmunoblastic T cell lymphoma. Viracta is also exploring the application of this approach to other EBV-associated conditions, such as nasopharyngeal carcinoma and gastric carcinoma. Founded in 2007 and rebranded from HemaQuest Pharmaceuticals in 2015, Viracta Therapeutics is actively conducting multiple clinical trials to advance its therapeutic candidates.

Ambiq Micro, Inc. is a fabless semiconductor company based in Austin, Texas, specializing in the development of ultra-low power integrated circuits tailored for power-sensitive applications. Founded in 2010, the company utilizes innovative subthreshold power optimized technology to create real-time clock and microcontroller products designed for wearables, smart cards, wireless sensors, and Internet-of-Things devices. By focusing on ultra-low-power mixed-signal solutions, Ambiq Micro aims to enhance the efficiency of wireless electronics, facilitating the creation of devices that either minimize or eliminate battery use while maximizing design flexibility. The company also provides technical support services and operates additional offices in San Jose, California, as well as in Shanghai, Shenzhen, and Taiwan.

Artilux is a technology company specializing in advanced optical connectivity solutions and 3D time of flight (ToF) technology. The company develops high-performance integrated circuits (ICs) that cater to a range of applications, from short-range consumer uses at 10-40G to long-range 100G data center links. Artilux is committed to innovation, having discovered GeSi, a novel 3D photosensitive material, which positions the company to enhance next-generation mobile devices. By embedding advanced optical and RF technologies into its products, Artilux aims to facilitate seamless and instantaneous data transfer, whether for consumer electronics or cloud-based applications.

C4 Therapeutics is a biopharmaceutical company developing targeted protein degradation therapies using its proprietary Degronimid platform. This platform enables the selective destruction of disease-causing proteins, expanding the scope of treatable conditions and potentially reducing drug resistance. The company focuses on oncology indications and has strategic collaborations with industry leaders.

Pavilion Data Systems Inc. is a technology company based in San Jose, California, specializing in the design and development of NVMe-over-Fabric storage platforms. The company focuses on enabling real-time performance at scale for massively-parallel applications, offering solutions that cater to sectors such as financial services, government, cloud services, media and entertainment, and research facilities. Pavilion's innovative architecture features Hyperparallel Flash Arrays, which utilize multiple controllers to surpass the limitations of traditional storage systems, providing ultra-low latency and linear scalability. By introducing a unique model called OPENCHOICE, Pavilion challenges conventional approaches to storage procurement and deployment. Founded in 2011, Pavilion Data Systems also has offices in Schiphol, the Netherlands, and Pune, India, and is recognized as a leader in a new category of storage appliances that aims to meet the ever-increasing demand for data throughput.

EirGenix is a Taiwan-based contract development and manufacturing organization that specializes in biologics. It offers cell line development and cell bank manufacturing, process development, analytical sciences and quality control, and cGMP manufacturing, including antibody-drug conjugate production. The company operates two business units: contract development and manufacturing operation and product development operation, applying its team’s experience to biosimilars, biobetters, and new biologics. It runs two PIC/S GMP facilities for mammalian and microbial production to support clinical trial and commercial manufacturing. Founded in 2012 and headquartered in New Taipei City, EirGenix also develops and provides biopharmaceutical products such as CRM197 carrier protein and a COVID-19 antigen rapid test.

ARRIS specializes in developing additive molding technology for manufacturing large-scale 3D-aligned continuous fiber thermoplastic composite parts. Its innovative process combines aligned fibers, electronics, and metallic components within topology-optimized structures, serving industries such as aerospace, automotive, and consumer products.

Regenacy Pharmaceuticals is a Boston-based biopharmaceutical company founded in 2016 that develops therapies for peripheral neuropathies, hemoglobinopathies and certain oncology indications. Its approach centers on restoring normal protein function with oral, isoform-selective histone deacetylase inhibitors. The company is advancing drug programs that include ricolinostat to address sickle cell disease and beta-thalassemia, as well as additional HDAC inhibitor–based therapies for neuropathies and related conditions.

Landing AI is a company that specializes in artificial intelligence transformation programs tailored for the manufacturing industry. Founded in 2017 and based in Palo Alto, California, the company develops solutions focused on visual inspection, automation, calibration, and automated issue identification. Its offerings cater to a diverse range of sectors, including manufacturing, retail, automotive, agriculture, telecommunications, and pharmaceuticals. The company aims to empower organizations to become AI-driven by providing a platform that enhances the accuracy of machine learning models through effective data generation and labeling. This platform helps identify environmental issues and alerts users to model changes, thereby facilitating efficient data management and accelerating troubleshooting processes. Founded by Dr. Andrew Ng, a prominent figure in AI, Landing AI is positioned to deliver practical AI solutions that drive value for businesses globally.

AEye, Inc. is a technology company focused on developing advanced vision hardware, software, and algorithms for autonomous vehicles and advanced driver assistance systems (ADAS). The company’s proprietary 4Sight Intelligent Sensing Platform integrates solid-state active LiDAR with artificial intelligence and a low-light HD camera, enabling precise and reliable perception of surroundings. AEye's products, including the 4Sight A and 4Sight M sensors, along with its iDAR platform, are designed to improve safety and performance in dynamic applications by providing faster, more accurate information. The AE100 Robotic Perception System and the modular AE200 sensor further exemplify AEye’s commitment to high-performance sensing solutions. Founded in 2013 and headquartered in Dublin, California, AEye also has a global presence with offices in Germany and Korea, serving a diverse customer base primarily in the United States, Europe, and the Asia-Pacific region.

Ambiq Micro, Inc. is a fabless semiconductor company based in Austin, Texas, specializing in the development of ultra-low power integrated circuits tailored for power-sensitive applications. Founded in 2010, the company utilizes innovative subthreshold power optimized technology to create real-time clock and microcontroller products designed for wearables, smart cards, wireless sensors, and Internet-of-Things devices. By focusing on ultra-low-power mixed-signal solutions, Ambiq Micro aims to enhance the efficiency of wireless electronics, facilitating the creation of devices that either minimize or eliminate battery use while maximizing design flexibility. The company also provides technical support services and operates additional offices in San Jose, California, as well as in Shanghai, Shenzhen, and Taiwan.

Metanoia Communications Inc., founded in 2004 and based in Hsinchu City, Taiwan, specializes in the development of semiconductor and software solutions for the wireline broadband and in-home networking markets. The company manufactures high-speed PHY chipsets, including products for VDSL2, G.fast, and G.hn technologies, targeting broadband manufacturers. Metanoia leverages advanced system architecture and algorithm expertise alongside its integrated circuit design capabilities to deliver a comprehensive range of fixed-line communication products suitable for access and in-home applications. As a subsidiary of ELAN Microelectronics Corporation, Metanoia is positioned to meet the growing demands of high-speed internet connectivity.

DSP Concepts Inc. is a leading provider of audio development tools and intellectual property for creators of audio-enabled products, headquartered in Santa Clara, California, with additional offices in Massachusetts, Germany, and China. The company's flagship product, Audio Weaver, is a cross-platform audio-processing engine that simplifies audio innovation by allowing engineers to rapidly prototype and modify designs across teams. DSP Concepts also offers TalkTo, a suite of proprietary machine learning and microphone processing algorithms designed to enhance audio clarity in noisy environments. Their technology supports multiple audio input and output streams, making it suitable for diverse applications, including automotive systems, soundbars, smart speakers, and IoT devices. Through design and consulting services, DSP Concepts assists in automotive audio design, system architecture, and custom protocol development, enabling developers to bring their products to market efficiently while minimizing risks. Their solutions are utilized by renowned brands across various sectors, ensuring a remarkable audio experience in countless consumer and automotive products.

Oculii Corp., based in Beavercreek, Ohio, specializes in developing advanced radar sensors and AI software for various applications, including intelligent transportation, automotive, aerial, and consumer sectors. The company's key products are radar sensors that provide real-time 4D tracking information, enabling accurate 3D positioning and speed detection. These sensors are used in automotive safety systems, traffic management, airborne and medical applications, as well as automated speed enforcement systems. Oculii's innovative Virtual Aperture Imaging radar technology enhances radar resolution without increasing the physical size of the sensor, making it more affordable and scalable. The company collaborates with industry leaders to deliver high-performance, all-weather, and low-cost perception technology for autonomous systems.

Oculii Corp., based in Beavercreek, Ohio, specializes in developing advanced radar sensors and AI software for various applications, including intelligent transportation, automotive, aerial, and consumer sectors. The company's key products are radar sensors that provide real-time 4D tracking information, enabling accurate 3D positioning and speed detection. These sensors are used in automotive safety systems, traffic management, airborne and medical applications, as well as automated speed enforcement systems. Oculii's innovative Virtual Aperture Imaging radar technology enhances radar resolution without increasing the physical size of the sensor, making it more affordable and scalable. The company collaborates with industry leaders to deliver high-performance, all-weather, and low-cost perception technology for autonomous systems.

Tripresso is an online travel agency based in Taipei, Taiwan, founded in 2013. The company specializes in package tour products, initially providing a marketplace for suppliers and a simple search engine for customers seeking suitable travel options. Over time, Tripresso expanded its offerings to include hotels, flight tickets, and customized travel plans for outbound travel. In 2018, it introduced TripSaaS, a proprietary software-as-a-service platform designed for brick-and-mortar travel agencies. This system facilitates the management of websites, product listings, orders, and customer relationships, ultimately enhancing operational efficiency. By leveraging data and partnerships with both online and offline travel information sources, Tripresso creates efficient travel planning networks that help users discover affordable travel packages.

Viracta Therapeutics, Inc. is a clinical-stage drug development company based in Cardiff, California, that specializes in precision oncology focused on virus-associated malignancies. The company utilizes a viral activation therapy platform to develop treatments for cancers linked to the Epstein-Barr Virus (EBV) and other virus-related diseases. Its lead investigational drug, nanatinostat, is being evaluated in combination with the antiviral valganciclovir as a potential oral therapy for EBV-positive lymphoma, including post-transplant lymphoproliferative disorder, plasmablastic lymphoma, and angioimmunoblastic T cell lymphoma. Viracta is also exploring the application of this approach to other EBV-associated conditions, such as nasopharyngeal carcinoma and gastric carcinoma. Founded in 2007 and rebranded from HemaQuest Pharmaceuticals in 2015, Viracta Therapeutics is actively conducting multiple clinical trials to advance its therapeutic candidates.

Pavilion Data Systems Inc. is a technology company based in San Jose, California, specializing in the design and development of NVMe-over-Fabric storage platforms. The company focuses on enabling real-time performance at scale for massively-parallel applications, offering solutions that cater to sectors such as financial services, government, cloud services, media and entertainment, and research facilities. Pavilion's innovative architecture features Hyperparallel Flash Arrays, which utilize multiple controllers to surpass the limitations of traditional storage systems, providing ultra-low latency and linear scalability. By introducing a unique model called OPENCHOICE, Pavilion challenges conventional approaches to storage procurement and deployment. Founded in 2011, Pavilion Data Systems also has offices in Schiphol, the Netherlands, and Pune, India, and is recognized as a leader in a new category of storage appliances that aims to meet the ever-increasing demand for data throughput.

Light Field Lab, Inc. is a technology company specializing in the development of holographic display systems that create immersive visuals by projecting three-dimensional holograms into physical space. Founded in 2017 and based in San Jose, California, the company leverages advanced light field technology to generate multiple viewing angles that mimic real-world perceptions, allowing objects to appear to float in space without the need for head-mounted displays. Light Field Lab's innovations enable new opportunities in both consumer and enterprise markets, facilitating the integration of existing content into their holographic formats through a universal application programming interface. The company's mission is to pioneer a holographic future, advancing how visual media is experienced across various applications.

Frequency Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to repairing or reversing damage caused by degenerative diseases through its innovative Progenitor Cell Activation approach. This method utilizes a combination of small molecules to activate progenitor cells in the body, which facilitates the creation of functional tissue without the complexities of genetic engineering. The company’s lead product candidate, FX-322, is currently undergoing phase 2a clinical trials aimed at treating the underlying causes of sensorineural hearing loss. In addition to FX-322, Frequency Therapeutics is exploring treatments for various degenerative conditions, including multiple sclerosis and diseases affecting muscle, the gastrointestinal tract, skin, and bone. Established in 2014 and based in Woburn, Massachusetts, Frequency Therapeutics has established a collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322.

Touché Solutions, formerly known as Mechavision, specializes in the manufacture of robot sensor modules and the development of plug-in robot haptic technology products. These technologies are integral to smart manufacturing applications and Internet of Things (IoT) services. The company's innovations have been utilized by Qisda for human-machine collaboration production lines. Touché Solutions is dedicated to research and development, aiming to enhance intelligent robotic development efficiently for its clients.

Tricorntech is a company specializing in semiconductor process control and environmental monitoring. It offers services for detecting volatile organic compounds and provides rapid air quality analysis applicable in diverse settings, from cleanrooms to urban environments. The company's product portfolio includes quality assurance for semiconductor processes, groundwater and soil contamination detection, and ambient air monitoring. Tricorntech serves a broad range of industries, including semiconductor, steel, petrochemical, food production, manufacturing, medical, and public environmental sectors, addressing the critical need for accurate monitoring and detection solutions in these fields.

Ambiq Micro, Inc. is a fabless semiconductor company based in Austin, Texas, specializing in the development of ultra-low power integrated circuits tailored for power-sensitive applications. Founded in 2010, the company utilizes innovative subthreshold power optimized technology to create real-time clock and microcontroller products designed for wearables, smart cards, wireless sensors, and Internet-of-Things devices. By focusing on ultra-low-power mixed-signal solutions, Ambiq Micro aims to enhance the efficiency of wireless electronics, facilitating the creation of devices that either minimize or eliminate battery use while maximizing design flexibility. The company also provides technical support services and operates additional offices in San Jose, California, as well as in Shanghai, Shenzhen, and Taiwan.

Frequency Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to repairing or reversing damage caused by degenerative diseases through its innovative Progenitor Cell Activation approach. This method utilizes a combination of small molecules to activate progenitor cells in the body, which facilitates the creation of functional tissue without the complexities of genetic engineering. The company’s lead product candidate, FX-322, is currently undergoing phase 2a clinical trials aimed at treating the underlying causes of sensorineural hearing loss. In addition to FX-322, Frequency Therapeutics is exploring treatments for various degenerative conditions, including multiple sclerosis and diseases affecting muscle, the gastrointestinal tract, skin, and bone. Established in 2014 and based in Woburn, Massachusetts, Frequency Therapeutics has established a collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322.